Financial Data and Key Metrics Changes - The company reported third quarter adjusted EPS of $0.50, exceeding previous expectations, and increased the full-year adjusted EPS forecast to at least $2 from $1.75 [4][5][25] - Premium and service revenue for the third quarter was $44.9 billion, with a GAAP loss per share of $13.50 due to a $6.7 billion non-cash goodwill impairment charge [25][32] - The adjusted effective tax rate was temporarily low, contributing approximately $0.10 to adjusted EPS, with an expected full-year adjusted tax rate of 20% to 21% [25][10] Business Line Data and Key Metrics Changes - The Medicaid segment achieved a third quarter HBR of 93.4%, aided by improved revenue from Florida's Children's Medical Services, which included a net $150 million positive revenue adjustment [10][25][26] - The Medicare segment's HBR was reported at 94.3%, reflecting typical cost patterns, with Medicare Advantage showing elevated medical cost trends consistent with expectations [18][25] - The Marketplace segment ended the quarter with approximately 5.8 million members, slightly better than expectations, despite experiencing medical cost pressure in September [15][25] Market Data and Key Metrics Changes - Medicaid membership stood at 12.7 million, with expectations of slight attrition in the coming quarters [27] - The company anticipates a 2025 Medicaid composite rate adjustment of roughly 5.5%, up from earlier estimates [8] - The Marketplace segment is preparing for potential market contraction in the high teens to mid-30s range due to the expiration of EAPTCs [40][45] Company Strategy and Development Direction - The company is focused on margin recovery over membership growth, particularly in the Marketplace segment, with pricing actions taken to support margin expansion in 2026 [39][51] - Continued advocacy for improved Medicaid rates and program changes is a priority, with efforts to manage high-cost drugs and enhance clinical management [11][14][57] - The company plans to provide detailed 2026 guidance in early February, emphasizing operational improvements and efficiency gains [22][23] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the overall performance of the business, despite challenges in the operating environment, and highlighted the importance of being responsible stewards of taxpayer dollars [24][60] - The company is closely monitoring trends in Medicaid and Marketplace utilization, with proactive measures in place to address potential challenges [10][37] - Management remains optimistic about the long-term viability of the individual health insurance market, despite uncertainties surrounding EAPTCs [17][40] Other Important Information - The company reported strong cash flow from operations of $1.4 billion in Q3, with unregulated cash on hand at $357 million [33] - The medical claims liability totaled $21.5 billion, representing 48 days in claims payable, an increase of one day compared to the previous quarter [33] - The company is prepared to harvest unrealized losses in Q4 to improve investment income trajectory for 2026 [31] Q&A Session Summary Question: How does the company ensure stability in the Marketplace amid competitor exits? - Management noted a slight uptick in utilization in September, correlating with national discussions on rate increases and EAPTCs, and emphasized prudent coverage for Q4 [36][37][40] Question: What efforts are in place to re-engage potential enrollees in the Marketplace? - The company is prepared to mobilize marketing efforts and broker relationships to recapture members who may not re-engage during open enrollment [42][44] Question: What is the outlook for Medicaid margins in 2026? - Management indicated that while 2026 is expected to be a trough year, they are focused on maintaining consistent profitability and margin improvement [68]

Core Insights - Centene Corporation reported a third-quarter 2025 adjusted earnings of 50 cents, significantly beating the consensus loss of 14 cents per share, although down from $1.62 a year ago [1] - The company's sales increased by 18.2% year-over-year to $49.69 billion, surpassing the consensus estimate of $47.75 billion [1] Financial Performance - Premium and service revenues rose by 22% to $44.89 billion, driven by growth in the PDP business, overall market growth in the Marketplace business, and rate increases in the Medicaid business, despite a decline in Medicaid membership [3] - The Health Benefits Ratio (HBR) increased to 92.7% in the quarter, up from 89.2% in the same period last year [3] Membership Trends - Total membership across Centene's portfolio decreased to 27.97 million from 28.64 million a year ago, mainly due to a reduction in Medicaid membership from 13.07 million to 12.71 million [4] - Conversely, Marketplace enrollment grew by 29.5% to 5.83 million, and Medicare PDP expanded by 17.8% to 7.97 million [4] Guidance and Outlook - Centene raised its fiscal 2025 adjusted earnings per share guidance from $1.75 to $2.00, compared to the consensus of $1.68 [4]

Core Viewpoint - Centene (CNC) reported quarterly earnings of $0.5 per share, significantly exceeding the Zacks Consensus Estimate of a loss of $0.21 per share, marking an earnings surprise of +338.10% [1] - The company generated revenues of $49.69 billion for the quarter ended September 2025, surpassing the Zacks Consensus Estimate by 4.35% and showing an increase from $42.02 billion year-over-year [2] Financial Performance - Centene's earnings for the previous year were $1.62 per share, indicating a decline in profitability [1] - The company has surpassed consensus EPS estimates three times over the last four quarters [2] - The current consensus EPS estimate for the upcoming quarter is -$0.87, with projected revenues of $47.41 billion, while the estimate for the current fiscal year is $1.69 on $190.45 billion in revenues [7] Market Position - Centene shares have underperformed, losing about 45.2% since the beginning of the year, compared to a 17.2% gain in the S&P 500 [3] - The Zacks Rank for Centene is currently 5 (Strong Sell), indicating expectations of underperformance in the near future [6] Industry Outlook - The Medical - HMOs industry, to which Centene belongs, is currently ranked in the bottom 26% of over 250 Zacks industries, suggesting a challenging environment [8] - Empirical research indicates a strong correlation between near-term stock movements and trends in earnings estimate revisions, which could impact Centene's stock performance [5]

Health insurer Centene reported a $6.6 billion third-quarter loss as the company struggles to control rising healthcare costs in the government-subsidized health plans it administers and sells. In this photo is the building housing Centene Corporation headquarters is seen Thursday, July 2, 2015, in Clayton, Mo. . (AP Photo/Jeff Roberson)ASSOCIATED PRESSHealth insurer Centene reported a $6.6 billion third-quarter loss as the company struggles to control rising healthcare costs in the government-subsidized he ...

Core Insights - Ventripoint Diagnostics Ltd. has partnered with Providence Health Care Ventures to validate its VMS+™ platform at St. Paul's Hospital, aiming to reduce reliance on cardiac MRI through AI-enhanced echocardiography [1][4] - The VMS+™ platform generates 3-D heart models from 2-D echocardiography images and has shown clinical agreement with MRI measurements, potentially allowing some patients to avoid MRI altogether [2][3] - The collaboration seeks to assess the performance of VMS+™ in real-world settings, focusing on workflow integration, MRI referral reductions, and cost efficiencies [4][5] Company Overview - Ventripoint is recognized for its application of AI in echocardiography, with its VMS products utilizing proprietary Knowledge Based Reconstruction technology to provide accurate cardiac measurements comparable to MRI [7][8] - The VMS+™ platform is FDA-cleared and Health Canada-licensed, compatible with existing 2D ultrasound systems, which allows healthcare systems to enhance imaging capacity without the need for new equipment [2][8] Clinical Evidence - VMS+™ has been successfully implemented in various clinical settings, including the Hospital for Sick Children and Mayo Clinic, demonstrating its effectiveness in aligning echo-derived measurements with cardiac MRI [3] - Recent presentations at conferences have highlighted the platform's ability to provide results comparable to MRI, particularly in assessing adult congenital heart defect patients [3] Future Prospects - The collaboration with PHC Ventures is set to begin in November 2025, with implementation expected in early 2026, aiming to validate the impact of VMS+™ across different healthcare settings [6] - The technology is anticipated to improve access to advanced cardiac diagnostics, especially in rural and Indigenous communities where MRI availability is limited [5][6]

Core Insights - Centene reported a loss in the third quarter as enrollees in Affordable Care Act plans sought more expensive medical care, highlighting the ongoing challenges faced by health insurers in restoring previous profit levels [1] Financial Performance - The company experienced a significant financial downturn, indicating a shift in enrollee behavior towards higher-cost medical services, which has adversely affected profitability [1] Industry Context - The struggles of Centene reflect broader issues within the health insurance industry, as companies grapple with rising healthcare costs and changing consumer demands [1]

Core Insights - Centene's health benefits ratio increased to 92.7% in the quarter, up from 89.2% in the same period last year [1] Financial Performance - The health benefits ratio reflects the percentage of revenue spent on medical care, indicating a rise in costs relative to revenue [1]

Core Insights - Centene reported a surprise profit for the third quarter, attributed to a low tax rate [1] Financial Performance - The company achieved a profit in the third quarter, which was unexpected [1] - The low tax rate played a significant role in enhancing the company's profitability [1]

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Financial Performance - Centene Corporation reported total revenues of $49.69 billion for Q3 2025, a 18.2% increase from $42.02 billion in Q3 2024 [30] - Premium and service revenues reached $44.90 billion, up 22% from $36.90 billion in the same period last year [16][30] - The company experienced a GAAP diluted loss per share of $(13.50) due to a non-cash goodwill impairment of $6.7 billion [30][16] - Adjusted diluted earnings per share (EPS) were $0.50, reflecting a $0.10 benefit from a low adjusted effective tax rate [5][16] Membership Growth - Total at-risk membership stood at 27.97 million as of September 30, 2025, compared to 28.64 million in 2024 [3] - Traditional Medicaid membership decreased to 11.12 million from 11.48 million year-over-year, while Marketplace membership increased significantly to 5.83 million from 4.50 million [3][5] Cost and Expense Management - The health benefits ratio (HBR) was 92.7%, up from 89.2% in Q3 2024, primarily due to increased medical costs in the Marketplace and Medicaid segments [16] - Selling, general, and administrative (SG&A) expense ratio improved to 7.0% from 8.3% in the prior year, driven by leveraging expenses over higher revenues [16] Outlook and Guidance - The company updated its full-year 2025 adjusted diluted EPS forecast to at least $2.00, an increase of $0.25 from previous guidance [10] - The GAAP diluted loss per share forecast for the full year is updated to not exceed $(12.85) [10] Community Engagement and Recognition - Centene was recognized in the inaugural 2025 Forbes® America's Best Employers for Company Culture™ list, highlighting high employee satisfaction [6] - The company announced various community engagement initiatives, including investments in mental health programs and the opening of a community health center in Texas [6]